{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:20:58Z","timestamp":1789928458052,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.brainresbull.2003.09.021","type":"journal-article","created":{"date-parts":[[2003,12,4]],"date-time":"2003-12-04T06:59:03Z","timestamp":1070521143000},"page":"231-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["White matter lesions in Fabry disease occur in \u2018prior\u2019 selectively hypometabolic and hyperperfused brain regions"],"prefix":"10.1016","volume":"62","author":[{"given":"David F.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheona","family":"Altarescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.Craig","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Patronas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Herscovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Schiffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2003.09.021_BIB1","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","article-title":"Enhanced endothelium-dependent vasodilation in Fabry disease","volume":"32","author":"Altarescu","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.STR.17.6.1084","article-title":"Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors","volume":"17","author":"Awad","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1227\/00006123-198702000-00004","article-title":"Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups","volume":"20","author":"Awad","year":"1987","journal-title":"Neurosurgery"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB4","unstructured":"J.C. Baron, Positron Emission Tomography, in: H. Barnett, J.P. Mohr, B.M. Stein, F.M. Yatsu (Eds.), Stroke, Philadelphia, 1998, pp. 101\u2013120."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry disease: ceramide trihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB6","first-page":"538","article-title":"Alternative formula for glucose utilization using labeled deoxyglucose","volume":"23","author":"Brooks","year":"1982","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1109\/42.712135","article-title":"Design and construction of a realistic digital brain phantom","volume":"17","author":"Collins","year":"1998","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB8","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","article-title":"Quantitative analysis of cerebral vasculopathy in patients with Fabry disease","volume":"50","author":"Crutchfield","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"DeGraba","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB10","unstructured":"R. Desnick, Y.A. Ioannou, C.M. Eng, \u03b1-Galactosidase A deficiency: Fabry disease, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease, 8th ed., McGraw-Hill, New York, 2001, pp. 3733\u20133774."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ana.410310410","article-title":"Fabry disease: immunocytochemical characterization of neuronal involvement","volume":"31","author":"deVeber","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF00296496","article-title":"Leptomeningeal lipid storage patterns in Fabry disease","volume":"88","author":"Elleder","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hbm.460030303","article-title":"Spatial registration and normalization of images","volume":"2","author":"Friston","year":"1995","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archneur.1973.00490220039004","article-title":"The central nervous system in Fabry\u2019s disease","volume":"28","author":"Grunnet","year":"1973","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archneur.1987.00520130013009","article-title":"Leuko-araiosis","volume":"44","author":"Hachinski","year":"1987","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00006231-199612000-00008","article-title":"Vasoreactive effect of acetazolamide as a function of time with sequential PET 15O-water measurements","volume":"17","author":"Hayashida","year":"1996","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB17","doi-asserted-by":"crossref","unstructured":"C.R.o.t.M.G. Hospital, Case 2-1984, N. Engl. J. Med. (1984) 106\u2013114.","DOI":"10.1056\/NEJM198401123100208"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/jnnp.36.6.1053","article-title":"Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain","volume":"36","author":"Kahn","year":"1973","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410230513","article-title":"Nervous system involvement in Fabry\u2019s disease: clinicopathological and biochemical correlation","volume":"23","author":"Kaye","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/01.STR.29.5.1058","article-title":"White matter changes in the gerbil brain under chronic cerebral hypoperfusion","volume":"29","author":"Kurumatani","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1258\/0007142001903229","article-title":"Pathology of small vessel stroke","volume":"56","author":"Lammie","year":"2000","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archneur.1971.00490040077009","article-title":"The central nervous system in Fabry\u2019s disease. A clinical, pathological, and biochemical investigation","volume":"25","author":"Lou","year":"1971","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/jnnp.69.1.48","article-title":"Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI","volume":"69","author":"Markus","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry\u2019s disease","volume":"40","author":"Mitsias","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB25","unstructured":"J.P. Mohr, H. Mast, Binswanger\u2019s disease, in: H.J.M. Barnett, J.P. Mohr, B.M. Stein, F.M. Yatsu (Eds.), Stroke, Pathophysiology, Diagnosis, and Management, Churchill Livingstone, New York, 1998, pp. 921\u2013933."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB26","doi-asserted-by":"crossref","unstructured":"D.F. Moore, G. Altarescu, P. Herscovitch, R. Schiffmann, Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease, Biomed. Central Neurol. (2002).","DOI":"10.1186\/1471-2377-2-4"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1552-6569.2001.tb00051.x","article-title":"Selective arterial distribution of cerebral hyper-perfusion in Fabry disease","volume":"11","author":"Moore","year":"2001","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1651-2227.2002.tb03114.x","article-title":"Elevated CNS average diffusion constant in Fabry disease","volume":"91","author":"Moore","year":"2002","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB29","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyper-perfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB30","unstructured":"D.F. Moore, F. Ye, R. Schiffmann, J.A. Butman, Increased pulvinar T1 signal intensity\u2014a pathognomonic MRI sign of Fabry disease, AJNR Am. J. Neuroradiol. 24 (2003) 1096\u20131101."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB31","doi-asserted-by":"crossref","unstructured":"L. Pantoni, J.H. Garcia, Pathogenesis of leukoaraiosis, Stroke 28 (1997) 652\u2013659.","DOI":"10.1161\/01.STR.28.3.652"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB32","unstructured":"B.R. Ransom, S.G. Waxman, R. Fern, Molecular pathophysiology of white matter anoxiv\/ischemic injury, in: H. Barnett, J.P. Mohr, B.M. Stein, F.M. Yatsu (Eds.), Stroke, Churchill-Livingstone, Philadelphia, 1998, pp. 101\u2013119."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB33","first-page":"147","article-title":"Correlation of neuropsychological, morphological and functional (regional cerebral blood flow and glucose utilization) findings in cerebral microangiopathy","volume":"39","author":"Sabri","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s00415-003-1133-x","article-title":"Postischemic cutaneous hyperperfusion in the presence of forearm hypoperfusion suggests sympathetic vasomotor dysfunction in Fabry disease","volume":"250","author":"Stemper","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB35","first-page":"12","article-title":"Increased glucose utilization in Salla disease (free sialic acid storage disorder)","volume":"40","author":"Suhonen-Polvi","year":"1999","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00697017","article-title":"Neuropathological and biochemical studies in Fabry\u2019s disease","volume":"30","author":"Tabira","year":"1974","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00690579","article-title":"Anderson-Fabry\u2019s disease: neuropathological and neurochemical investigations","volume":"56","author":"Tagliavini","year":"1982","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-510X(00)00286-0","article-title":"Reduced cerebral glucose metabolism in subjects with incidental hyperintensities on magnetic resonance imaging","volume":"176","author":"Takahashi","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp.72.5.576","article-title":"Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis","volume":"72","author":"Yamauchi","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainresbull.2003.09.021_BIB40","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/1522-2594(200009)44:3<450::AID-MRM16>3.0.CO;2-0","article-title":"H215O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans","volume":"44","author":"Ye","year":"2000","journal-title":"Magn. Reson. Med."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923003002843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923003002843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:50:13Z","timestamp":1759780213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923003002843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0361923003002843"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2003.09.021","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"White matter lesions in Fabry disease occur in \u2018prior\u2019 selectively hypometabolic and hyperperfused brain regions","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2003.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}